# FDA Inspection 972350 - Biomat USA, Inc. - June 01, 2016

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/d9827a97-94a1-4d1a-ac8d-6d557f67fe7b
Source feed: FDA_Inspections

> FDA Inspection 972350 for Biomat USA, Inc. on June 01, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 972350
- Company Name: Biomat USA, Inc.
- Inspection Date: 2016-06-01
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1255916 - 2024-10-30](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/8685276f-8239-4da0-9a96-8160749ff121)
- [FDA Inspection 1255916 - 2024-10-30](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/ebbff36f-f897-4122-926a-156220bb2062)
- [FDA Inspection 1100472 - 2019-06-28](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/ae6ab48f-e6fc-439c-89ae-21cad6721ee8)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/3dd4450e-3dbf-4785-b422-4e8a45d79f74

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d